|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00348 CHINAHEALTHWISE
Nominal 
0.095 -0.001 (-1.042%) | 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Turnover | 113,575 | -22.377% | 146,317 | 142,058 | 170,079 | 137,853 |
| Cost of Sales | (76,226) | -11.389% | (86,023) | (88,788) | (79,085) | (76,797) |
| Gross Profit | 37,349 | -38.055% | 60,294 | 53,270 | 90,994 | 61,056 |
| 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | (216) | (166) | |
| Change in FV & Impairment on Others | (3,146) | -97.081% | (107,790) | (25,406) | (105,629) | (51,553) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (40,028) | -69.689% | (132,059) | (56,401) | (100,580) | (72,929) | |
| Taxation | (253) | -89.876% | (2,499) | 2,127 | (2,466) | 3,648 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | 44,059 | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (40,281) | -70.064% | (134,558) | (54,274) | (103,046) | (25,222) | |
| 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Finance Costs / (Income) | 8,299 | -7.717% | 8,993 | 7,297 | 6,410 | 18,839 |
| Depreciation & Amortisation | 7,170 | 27.694% | 5,615 | 3,304 | 4,198 | 8,748 |
| Directors' Emoluments | 9,091 | -52.306% | 19,061 | 20,161 | 15,609 | 14,515 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified (Modified Report) | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -5.230 | -70.046% | -17.460 | -7.040 | -13.370 | -3.250 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.019 | (0.037) | 0.055 | 0.015 |
| NBV per share ($) | (0.024) | -- | 0.006 | 0.180 | 0.251 | 0.385 |
| Remarks: | Real time quote last updated: 22/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -40,281,000 |
| %Change | -70.064% |
| EPS / (LPS) | HKD -0.052 |
| NBV Per Share ($) | HKD -0.024 |